Partnerships

At Lilly, we value partnerships. Our history has proven—and our strategy continues to prove—that by working together, we can discover, develop, and deliver the innovative pharmaceutical therapies that will help people live longer, healthier, and more active lives.

Collaborative Vision

We seek the best ideas, capabilities, and research available, whatever the source. Having excellent in-house talent and resources is one of the pillars of our R&D success, but at the same time, we're excited about the opportunities that exist to collaborate. Great work is being done in all corners of the world and in multiple settings. Our goal is to find it, advance it, and put it to work for the patients who need it.

Globally Networked Strategy

Our partnering strategy is consistent with what we all know about today's marketplace: no one can settle for business as usual, and no one company can go it alone. That's why we are continuing to transform Lilly from a fully integrated pharmaceutical company to a fully integrated pharmaceutical network (FIPNet). Within this more networked structure, we're teaming up to access innovation and capabilities, reduce costs, market products, manage risk, and accelerate productivity. As a result, we're focused on leveraging external compound innovation, capacity, capabilities, and partnerships around the world.

Straightforward Approach

We think the best way to establish a relationship is through a clear, straightforward process that enables us to respond rapidly and efficiently to potential partnering opportunities. And as the first pharma company to establish an office of alliance management, we continue to devote dedicated, experienced teams to ensure partnership success.